Thanks, Mark. I will now turn to our results for the quarter. As I mentioned earlier, calculated current billings defined as revenue recognized in the quarter, plus the current change in current deferred revenue grew 11% year-over-year to $302.2 million. This outperformance was largely driven by Tenable One and Cloud Security. Current RPO growth was 11% year-over-year, consistent with CCB growth. During the quarter, we added 485 new enterprise platform customers and 135 net new six-figure customers. This was a strong quarter for us and is indicative of our growing deal sizes. Our net dollar expansion rate was 108% this quarter. Our renewal rate remained strong. Now on to the P&L for the quarter. Revenue was $235.7 million, which represents 11% year-over-year growth. Revenue in the quarter exceeded the midpoint of our guided range by $4.7 million. Our percentage of recurring revenue remained high at 95%. Gross margin was 82% this quarter, up from 81% last quarter and is in line with expectations. Gross margin for the full year is 81%, up from 80% last year. Going forward, we continue to expect gross margins to be in the high 70%s to low 80% range. Sales and marketing expense was $80.1 million, down from $83.1 million last quarter, and as a percentage of revenue, was 34%, compared to 37% last quarter. Sales and marketing expense was lower sequentially on an absolute dollar basis and percentage basis, primarily due to improved sales efficiency, partially offset by higher sales commissions attributed to our sales performance and seasonally high renewal base in the quarter. For the full year, sales and marketing expense as a percentage of revenue was 37%, down from 42% last year, representing a 450-basis-point improvement, reflecting the strength of our go-to-market model. Looking ahead, we plan to add capacity this year, but expect sales and marketing spend as a percentage of revenue will continue to trend lower in 2025. R&D expense was $32.5 million, which was down from $35.6 million last quarter. R&D expense was lower this quarter in comparison to last quarter, primarily due to foreign tax credits received associated with investments and scaling our global engineering capabilities. R&D expense as a percentage of revenue was 14% this quarter, down from 16% last quarter. For the full year, R&D expense as a percentage of revenue was 15%, compared to 14% last year. G&A expense was $20.5 million, which was down from $21.1 million last quarter. G&A expense as a percentage of revenue was 9% this quarter, and for the full year, which was flat relative to last quarter, as well as for the full year 2023. Income from operations was $59.4 million and exceeded the midpoint of our guided range by $11.4 million. Operating margin for the quarter was 25%, which was 400 basis points better than the midpoint of our guided range. Operating margin for the full year is 20%, representing a 500-basis-point increase from the prior year. I’m very pleased with our ability to continue to drive leverage in the business, as operating margins have doubled from 10% for 2022 to 20% in 2024. EPS for the quarter was $0.41, which was $0.07 better than the midpoint of our guided range. Now let’s turn to the balance sheet. We finished the quarter with $577 million of cash and short-term investments, accounts receivable was $259 million and total deferred revenue was $833 million. Current deferred revenue was $650 million, which gives us a lot of visibility into expected revenue over the next 12 months. We generated a record $86 million of unlevered free cash flow this quarter, which is up compared to $61 million last quarter. For the full year 2024, we generated $238 million of unlevered free cash flow, exceeding the guide from our Q2 earnings call. We feel confident that we can continue to expand our operating free cash flow margins over the ensuing years, as we have done so for every year since our IPO. In October 2024, our Board of Directors increased the repurchase authorization under our share repurchase program by $200 million. During the quarter, we repurchased 1.2 million shares of our common stock for an aggregate purchase price of $50 million. Thus far, we have repurchased almost 2.7 million shares for $115 million since November of 2023 and have $185 million of remaining authorization. With the results of the quarter behind us, I’d like to discuss our outlook for Q1 and the full year 2025. Our guidance excludes the impact of the potential acquisition of Vulcan Cyber, which we expect to close shortly. For the first quarter, we currently expect revenue to be in the range of $232 million to $234 million. Non-GAAP income from operations to be in the range of $42 million to $44 million. Non-GAAP net income to be in the range of $35 million to $37 million, assuming interest expense of $7 million, interest income of $5.2 million and a provision for income taxes of $3.6 million, and non-GAAP diluted earnings per share to be in the range of $0.28 per share to $0.30 per share, assuming $124 million fully diluted weighted average share is outstanding. For the full year, we currently expect calculated current billing to be in the range of $1.4 billion to $1.5 billion. Revenue to be in the range of $971 million to $981 million. Non-GAAP income from operations to be in the range of $213 million to $223 million. Non-GAAP net income to be in the range of $189 million to $199 million, assuming interest expense of $28.3 million, interest income of $21 million and a provision for income taxes of $13.4 million. Non-GAAP diluted earnings per share to be in the range of $1.52 per share to $1.60 per share, assuming $124.5 million fully diluted weighted average share is outstanding. And unlevered free cash flow to be in the range of $285 million to $295 million. Let me provide some context related to our Tenable standalone outlook. The CCB outlook we’re providing today is consistent with the directional comments we provided last quarter. The one thing I would note is that our outlook is incrementally more cautious for U.S. Federal due to the transition of a new administration. It’s early in the year, so we look forward to updating you on our progress throughout the year. Our guidance for operating income reflects our emphasis on profitable growth. We typically front load our investments in sales and marketing and R&D early in the year. In terms of quarterly flow, we expect operating margin to generally increase throughout the year as some of these investments take hold. For the full year, our guide reflects a 200-basis-point improvement over 2024. It’s worth noting that on a standalone basis, we expect to deliver $285 million to $295 million of unlevered free cash flow in 2025, which is above the target that we previously provided. Our long-term expectation of 35% plus unlevered free cash flow margins over time is unchanged. Now, separate from the outlook and related commentary I just provided, Vulcan is expected to contribute an additional 50 basis points of growth to CCB and revenue for the full year, with a de minimis contribution to Q1. In terms of quarterly flow for the rest of the year, we expect the topline financial impact of Vulcan to occur largely in the second half of the year as we prioritize the product integration into Tenable One and go-to-market with the expansive remediation workflow ops in the second half of the year. Vulcan is also expected to add $11 million to $13 million of operating expenses and reduce unlevered free cash flow by $20 million, including transaction costs. We expect the transaction to be accretive in the first half of next year and for the full year 2026. So, with that, Mark and I would like to thank everyone for joining us on the call today. We’re very excited about the opportunity ahead and look forward to updating you throughout the year. We hope to see you at the Morgan Stanley, Susquehanna and Cantor Fitzgerald conferences in the coming weeks. We’d now like to open the call for questions.